Richard Reithinger

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

Visceral leishmaniasis: time to better use existing resources

Cutaneous leishmaniasis

Co-Infection of Leishmania (Viannia) braziliensis and HIV: report of a case of mucosal leishmaniasis in Cochabamba, Bolivia

Researchers are developing a new COVID vaccine for cancer patients

Rapid detection of Trypanosoma cruzi in human serum by use of an immunochromatographic dipstick test

Control of leishmaniasis

Nepal Health for Life

The diagnosis and treatment of cutaneous leishmaniasis

Ownership and use of insecticide-treated nets in Oromia and Amhara regional states of Ethiopia two years after a nationwide campaign

Risk factors for anemia in children under 6 years of age in Ethiopia: analysis of the data from the cross-sectional Malaria Indicator Survey, 2007

Richard Reithinger Joins RTI International's Global Health Group as Senior Director of Infectious Disease Programs

COVID-19 Proves We Need More Than Strong Health Systems

Model predicts monkeypox outbreaks in high-income European countries will have limited impact

The challenges of Chagas Disease-- grim outlook or glimmer of hope

Global malaria efforts: Progress made, but challenges loom ahead

The investment case for malaria elimination in Thailand: A cost-benefit analysis

Integrating nutrition assessments and seasonal malaria chemoprevention: Results from a mixed-methods feasibility study in Guinea

Global Fund names Richard Reithinger to Technical Review Panel

In vivo efficacy of artemether-lumefantrine and chloroquine against plasmodium vivax: A randomized open label trial in central Ethiopia

Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia